Product Theater - Alexion: Making a difference in the lives of patients living with hypophosphatasia
This Product Theater duration is 40 minutes.
As the only enzyme replacement therapy for people with perinatal/infantile-onset and juvenile-onset hypophosphatasia (HPP), STRENSIQ is an at-home prescription medication that provides: Skeletal healing and mobility.
Upon completion, participants will be able to understand
- more about the clinical manifestations of Hypophosphatasia.
- the impact of bone mineral density in patients with Hypophosphatasia.
- more about enzyme replacement therapy
Eric T. Rush, MD, FAAP
Clinical Geneticist, Associate Professor
Children’s Mercy Kansas City, University of Missouri - Kansas City School of Medicine
Dr. Eric Rush is a Clinical Geneticist at Children’s Mercy Hospital and the University of Kansas Medical Center. He is an Associate Professor of Pediatrics at the University of Missouri-Kansas City School of Medicine and a Clinical Associate Professor of Internal Medicine at the University of Kansas School of Medicine. He is the Underdown/Yeoman’s Family Endowed Professor in Connective Tissue Disorders Care. He is Board Certified in Pediatrics, Internal Medicine, and Clinical Genetics. He was previously the Medical Director of the osteogenesis imperfecta and metabolic bone clinics at Children’s Hospital and Medical Center in Omaha, Nebraska, and currently is the co-director of the Children’s Mercy Skeletal Dysplasia clinic and the Medical Director of the Children’s Mercy Office of Faculty Development.
Dr. Rush received Bachelor of Science degrees in Biochemistry and Biology with Concentration in Genetics at the University of Kansas in 2001. He received his medical degree at the University of Kansas School of Medicine, Kansas City, KS in 2005. He completed a residency in Internal Medicine and Pediatrics at the University of Nebraska Medical Center in 2009 and Chief Residency in Pediatrics at the University of Nebraska Medical Center in 2010. He finished his training with a Clinical Genetics fellowship at the University of Nebraska Medical Center in 2012.
Among his clinical interests are osteogenesis Imperfecta, hypophosphatasia, X-linked hypophosphatemia, cancer genetics, cardiovascular genetics, dysmorphology, Personalized Medicine, and Genetics of Common Disease. His research interests include extraskeletal manifestations of osteogenesis Imperfecta, best practices in the treatment of hypophosphatasia, skeletal pathology in peroxisomal biogenesis disorders, and molecular characterization of rare syndromes.
Dr. Rush’s professional affiliations include the American Academy of Pediatrics, the American Society for Bone and Mineral Research, the International Society for Clinical Densitometry, and Alpha Omega Alpha. He is on the Scientific Advisory Board for the Rare Bone Diseases Alliance and the Global Foundation for Peroxisomal Disease.
Alexion (Self) : Consultant (Status: Ongoing), Research Support (Status: Ongoing), Speaker's Bureau / Teaching Engagements (Status: Ongoing); Ascendis (Self) : Advisory Committee/Board Member (Status: Ongoing); Biomarin (Self) : Consultant (Status: Ongoing), Speaker's Bureau / Teaching Engagements (Status: Ongoing); Inozyme (Self) : Consultant (Status: Ongoing); Ipsen (Self) : Advisory Board (Status: Ongoing); Ultragenyx (Self) : Consultant (Status: Ongoing), Research Support (Status: Ongoing), Speaker's Bureau / Teaching Engagements (Status: Ongoing)
Suzanne Lee, BS (Moderator)
Thought Leader Liaison
Suzanne is a Thought Leader Liaison with Alexion Pharmaceuticals since June 2021. She has over 25 years of experience in Biotech/Pharma and hospital operations. Suzanne received her BS from Florida State University. She enjoys traveling, yoga, hiking, spending time with family and friends and her fur kid Scout. Go Noles!
Susan Starling Hughes, MS, CGC
Certified Genetic Counselor
Children’s Mercy Kansas City
Susan Starling Hughes, MS, CGC is a certified genetic counselor who works with pediatric patients and their families at Children’s Mercy Kansas City. She is a Teaching Assistant Professor of Pediatrics at the University of Missouri - Kansas City School of Medicine. Her primary clinical focus encompasses skeletal and connective disorders, including hypophosphatasia, osteogenesis imperfecta, and Ehlers-Danlos syndrome. Susan is an active member of the National Society of Genetic Counselors and has given many well-received presentations comprised of novel research. She is passionate about genetic education and rare disease awareness. Susan holds a Master’s degree in Genetic Counseling from Virginia Commonwealth University.